Motivation: Although sequencing-based technologies are becoming the new reference in genome analysis, comparative genomic hybridization arrays (aCGH) still constitute a simple and reliable approach for copy number analysis. The most powerful algorithms to analyze such data have been freely provided by the scientific community for many years, but combining them is a complex scripting task. Results: The cghRA framework combines a user-friendly graphical interface and a powerful objectoriented command-line interface to handle a full aCGH analysis, as is illustrated in an original series of 107 Diffuse Large B-Cell Lymphomas. New algorithms for copy-number calling, polymorphism detection and minimal common region prioritization were also developed and validated. While their performances will only be demonstrated with aCGH, these algorithms could actually prove useful to any copy-number analysis, whatever the technique used. Availability and implementation: R package and source for Linux, MS Windows and MacOS are freely available at
Introduction
Much progress has been made over the past decades in the detection of chromosome imbalances. From Giemsa banding to in-situ fluorescent hybridization (Speicher and Carter, 2005) , then from Comparative Genomic Hybridization (CGH) to array-based CGH (Theisen, 2008) , resolution and complexity have increased simultaneously. Current state-of-the-art CGH array techniques involve millions of oligonucleotide probes covering the whole genome (Conrad et al., 2010) , each of them the target of a competitive hybridization between matching sample and reference DNA labeled with distinct fluorescent dyes. Single nucleotide polymorphism (SNP) arrays can add an extra layer of information to this analysis scheme without increasing further the resolution, providing heterozygosity measurements able to refine copy-number models and identify copy-neutral losses of heterozygosity (Bignel et al., 2004) . While next-generation sequencing can theoretically further increase this resolution down to V C The Author 2017. Published by Oxford University Press. All rights reserved. For Permissions, please e-mail: journals.permissions@oup.com
Most of these tools are freely available, but conducting a complete analysis requires scripting abilities and time that can't always be afforded. Moreover available solutions implement selections of the available algorithms and rely on technologies (Almagro-Garcia et al., 2009; Chen et al., 2006; La Rosa et al., 2006) or licensing which prevents users from implementing them themselves. The open source framework we describe herein (cghRA) is written in the R scripting language used to implement most of the previously cited algorithms, concealing the user-friendliness of a graphical interface with the modularity of an object-oriented paradigm, making customization and extension straight-forward. As parts of these extensions, we also provide three original algorithms that we applied on a novel Diffuse Large B-Cell Lymphoma (DLBCL) dataset, in order to assess their validity and pinpoint recurring somatic events.
With an incidence rate of 7 new cases per 100 000 and per year (Howlader et al., 2014) , DLBCL is an aggressive disease that represents about 30% of Non-Hodgkin Lymphomas. It can be subdivided into two main molecular subtypes termed Activated B-Cell-like (ABC) and Germinal-Center B-cell like (GCB) (Alizadeh et al., 2000) with distinct outcomes (3-year survival of 50% and 80% respectively, Roschewski et al., 2014) . While many efforts have been made to describe the molecular features of these lymphomas (Lenz et al., 2008) , prognostic biomarkers and new therapeutic solutions are still lacking for the 30% of patients who relapse or do not respond to current treatments. We propose here to address this issue, applying cghRA to a series of 107 arrays intentionally enriched in refractory/relapsing patients.
Materials and Methods

Samples and arrays
The presented dataset aggregates 3 series of CGH arrays (Agilent Technologies, Santa Clara, CA), totaling 107 DLBCL samples.
Cryopreserved tumor DNA samples were extracted from lymph node biopsies at diagnosis, from patients treated in our facility. The first series consists of 18 samples with particularly unfavorable outcome, hybridized on 44B arrays (Agilent 13282) against a Promega normal DNA pool (Jardin et al., 2008) . Following the same protocol, the second series adds 51 samples hybridized on 4x44K arrays (Agilent 14950). A last series of 38 samples was hybridized on 105A arrays (Agilent 14698) against matching patient normal DNA, extracted from peripheral blood mononuclear cells.
Array pre-processing
Arrays were scanned and pre-processed using the manufacturer's Feature Extraction software, with the version at the time (8.5.1.1 for the 44B arrays, 9.5.1.1 for the 4x44K arrays and 9.5.3.1 for the 105A arrays). As this step includes background management and a MA lowess regression, no further signal-based normalization is included in the workflow described here. To deal with the waveeffect, a well-known bias in array-CGH data presumably due to local GC content (Leo et al., 2012; Leprêtre et al., 2010; van de Wiel et al., 2009) , the WACA algorithm (Leprêtre et al., 2010) was re-implemented in cghRA. Signal distributions among the physical arrays were visually checked using log-ratio plots, and no bias was detected. Replicated probe groups were replaced by their median log-ratios, in order to not overweight arbitrary locations housing replicates during segmentation.
To enforce design compatibility, the probe sequences were remapped to the GRCh37 assembly, as provided in the University of California Santa Cruz (UCSC) repository. The remapping was implemented in cghRA using the BLAT software (Kent, 2002) , allowing few gaps and mismatches. Probes mapping to multiple or overlapping genomic locations were discarded, as they potentially provided biased signals.
Raw and processed datasets can be freely downloaded from the EBI ArrayExpress database (http://www.ebi.ac.uk/arrayexpress), under the accession numbers E-MTAB-4495, E-MTAB-4496 and E-MTAB-4497.
Conventional karyotyping
For 77 of the 107 patients, cytogenetic analyses performed at diagnosis were also available. R-banded metaphases were karyotyped as previously reported (Tilly et al., 1991) , and chromosomal abnormalities were described according to the International System for Human Cytogenetic Nomenclature (International Standing Committee on Human Cytogenetic Nomenclature, 2005). Resulting formulas were curated to focus on copy number, and reformatted to simplify parsing (Supplementary Table S3 ).
Implementation
The whole cghRA workflow, including the novel algorithms presented here, is implemented in the R language (3.2.3), relying mainly on 'base' and 'stats' packages. Genomic feature handling and visualization is inherited from the 'Rgb' package class system (Mareschal et al., 2014) . Graphical interfaces were built using the 'tcltk' and 'tkrplot' packages.
Array processing
Model
To convert log-ratios to biologically relevant copy numbers, the cghRA workflow relies on a mixture of normal distributions, as several other algorithms do (Engler et al., 2006; Picard et al., 2005; van de Wiel et al., 2007) . The log-ratios are assumed to originate in a small set of discrete values, one for each copy number, and the distance practically measured to such values are assumed to be normally distributed technical noise. These methods differ as to how many distinct copy number states should be considered (3 for Engler et al., 6 for van de Wiel et al.) and as at which data level the model should be fitted (probes for Picard et al., segments for van de Wiel et al.) . The method we describe fits the model at the segment level, but differs from previously cited work on multiple points that will be introduced along with the method description here after.
While relying on the same assumptions, cghRA does not fit a model on raw log-ratios (LR), but rather on a transformation that we termed log-ratio related copy numbers (LCN). This transformation is based on the log-ratio definition and the technique-related assumption that the reference sample holds 2 copies of each chromosome, thus 2 copies of each probe (Equation 1).
As continuous measurements of discrete true copy numbers (TCN), these LCN are distributed around linearly spaced representative values (Equation 2). The measured difference between LCN and TCN is assumed to be normally distributed technical noise. This linear link between the various normal distribution means largely simplifies the model compared to previously published tools, and allows us to make no assumption on copy state count (virtually each integer value is a valid copy state).
When analyzing tumoral CGH arrays, the 'shrinking effect' caused by normal cell contamination in biopsy samples must also be considered. In clonal pathologies such as DLBCL (Swerdlow et al., 2008) , a biopsy sample can be seen as a mixture of two cellular populations: tumoral cells sharing the same genomic alterations, and normal cells supposed to have 2 copies of each probe (sample ¼ reference). Samples harbouring more than one clone are discussed in the Supplemental Text, however alternative models may be considered to handle efficiently samples with complex clonal architecture. As the fluorescence is measured on the whole sample, it reflects the average DNA amount across the various cell populations, weighted by their respective proportions (Equation 3). As a consequence, log-ratios tend toward 0 as the normal cell proportion increases and LCN tend toward 2 (Equation 1).
Combining all these observations, the cghRA copy model proposed here consists in centering LCN on the most common LCN (center) of known ploidy (2 in most cases), and reverse the 'shrinking effect' with the observed gap between consecutive distribution peaks (width) (Equation 4).
Implementation
Each array was segmented individually by the Circular Binary Segmentation (CBS) algorithm (Olshen et al., 2004; Venkatraman and Olshen, 2007) , implemented in the DNAcopy package, as it proved to perform consistently well on various biological samples (Hofmann et al., 2009; Willenbrock and Fridlyand, 2005) . As optimal values for the alpha and undo.SD parameters can vary between arrays, multiple segmentation profiles were applied and the fittest resulting model was retained. The estimation of the parameters for the model described above Equation (4) is implemented in the cghRA package. In contrast with previously published models (van de Wiel et al., 2007) , the model is fitted independently for each sample, as normal cell proportion can vary widely from one sample to another (Fig. 1) . The ploidy parameter is set a priori from another source (conventional karyotyping, flow cytometry, . . .) if available, or to 0 to obtain relative copy numbers.
Mean log-ratios of all segments from the studied sample are first converted into LCN (Equation 1). The distribution of these LCN is estimated using Gaussian kernels and the probe count of segments as weights (Fig. 1 ). Peaks are detected in the estimated density function as local maxima with densities larger than 1% of the maximum density observed along the LCN axis. The LCN of the peak with maximal density is used as center estimate, and the median of the LCN differences between consecutive peaks as width. In the current implementation, the Gaussian noise is discarded by rounding estimated TCN to the closest integers.
As the density estimation relies heavily on the bandwidth used, several models are fitted with bandwidths ranging from 0.02 to 0.5. The segment to model (STM) distance is computed for each resulting model and the one leading to the lowest STM is kept. This distance is the sum of the absolute difference between modeled and measured Fig. 1 . Impact of the cellularity on copy-calling. The distribution of log-ratios across the genome is plotted for two arrays with distinct tumor cell contents (estimated to 31.5% and 84.9% respectively). Segments are represented with crosses, according to their mean log-ratios (x axis) and sizes (probe counts, y axis). A Gaussian-Kernel density is plotted on this distribution, and local maxima used for modeling are represented by vertical bars. Estimated copy numbers are presented on the bottom axis, and vary according to the estimated cellularity. Segments corresponding to the sexual chromosomes are represented by dots, as they do not necessarily respect this model copy number of each segment seg from the genomic segmentation S of a sample, weighted by the proportion of probes the segment involves (Equation 5). Using the Equation 4, the mean log-ratio of each segment is turned into a TCN estimate, and consecutive segments with same TCN are merged.
Validation
To assess the performances of the proposed software, CGH array analysis was also performed with two equivalent algorithms from the Bioconductor project (http://bioconductor.org). CGHcall 2.18.0 (van de Wiel et al., 2007) , which relies on a comparable model, and GLAD 2.24.0 (Hupé et al., 2004) , a reference in the field. While cghRA offers a user-friendly interface for manual model tuning, automatic models were left unchanged to provide an objective comparison. The three datasets were compared to results obtained by conventional karyotyping, averaging copy number distances over all segments seg from the genomic segmentation S of a sample (Equation 6). As GLAD is a 3 state model (loss, normal, gain) and the latest CGHcall version proposes a 5 state model (double deletions, loss, normal, gain, amplifications), cghRA and karyotype absolute copy numbers were classified accordingly to compute comparable distances (Supplementary Table S1 ).
In the 17 polyploid samples (3n and 4n, as determined by conventional karyotyping), cghRA to karyotype distances were found smaller than GLAD to karyotype distances (paired Wilcoxon's P ¼ 0.0443, Fig. 2A ). In the 49 diploid samples, the same tendency was found but was no longer significant (P ¼ 0.541, Fig. 2B ). cghRA proved significantly better to retrieve conventional karyotype states than CGHcall, both in polyploid (P ¼ 4.20e-4) and diploid (P ¼ 1.55e-11) tumors. The difference between cghRA and GLAD models was further explored by examining the proportion of probes conforming to their respective sample ploidies (a generalization of 'normal probes' to polyploid genomes). As can be seen in Figure 2C , cghRA agreed with conventional karyotypes (respective medians of 84.15% and 84.11%) while GLAD showed a significant tendency to overestimate the proportion of unaltered probes (87.38%, paired Wilcoxon's P ¼ 0.025). This suggests a lack of sensitivity from GLAD for some events large enough to be detected at karyotype resolution, especially in complex polyploid genomes where their amplitude is lessened (P ¼ 0.0031).
4 Polymorphism filtering
Implementation
As 69 of the 107 arrays were hybridized against a pool of reference DNA rather than matching normal DNA samples, constitutive copy number variations (CNV) are expected to be detected as well. To filter out such false positives, altered regions were scored using human polymorphism data publicly available in the Database of Genomic Variants (Iafrate et al., 2004) . To avoid the pitfalls of such an approach pinpointed by previous studies (Bastida-Lertxundi et al., 2014; Duclos et al., 2011) , several precautions were taken. In order to enforce break point precision, only 3 015 103 supporting variants from large studies (20 samples at least) based on high resolution techniques (SNP or CGH arrays, next-generation sequencing) were considered (DGV version 2014-10-16).
To limit the impact of the design on genomic coordinates, overlaps were computed in probe counts, considering the design of the CGH series to filter. DGV supporting variants are remapped to the considered design, simulating the results that could be expected with the user technology, and filtering out undetectable events. Overlaps between segments to score (s) and DGV polymorphisms (p) are then quantified using the Jaccard index (Equation 7), i.e. the probe count ratio between the intersection and the union of s and p considering both as probe sets, which ranges from 0 for exclusive events to 1 for perfect overlaps.
As a single observed event may actually be the combination of multiple polymorphisms, tiling paths (P) of multiple DGV supporting variant are considered as well. The resulting score is penalized by the power of the component count, to account for the unlikeliness of such conjoint events, especially when it leads to poor overlap (Equation 8). To minimize computation, only variants increasing the Jaccard index of 0.1 or more are retained.
True polymorphisms are expected to be found several time in the DGV, across one or many studies with potentially distinct designs. Thus multiple tilling paths of DGV supporting variants are built in an iterative way, using each variant at most once. A new path is initiated with the best overlapping variant remaining, and expanded with other variants if they sufficiently enhance the overlap as described above. The variants composing the path are then discarded, and the process is repeated until no remaining variant overlaps the segment to score with a Jaccard index of 0.1 or more. The final score considered for filtering a segment s is the sum of the scores of all n constructed path, penalized by their rank A B C Fig. 2 . cghRA copy-calling algorithm validation. Panels (A) and (B) illustrate the distances observed between copy numbers estimated by various techniques, for hyperdiploid and diploid samples respectively. Copy numbers were compared between two techniques across the genome of each sample, and weighted by the size of the considered regions (in base pairs). Average distances across samples are presented on the edges and Mann-Whitney tests were conducted to determine whether an algorithm was significantly closer to the karyotype than another. Panel (C) describes the proportion of probes showing the expected ploidy (i.e. not presenting a specific copy gain or loss) according to three techniques: conventional karyotyping (inference based on genomic coordinates), cghRA and GLAD
(Equation 9
). This penalization allows to focus on quality rather than quantity of overlaps, and the implementation of an early stopping rule as O i tend toward 0 when i increases, except for perfect overlaps.
Validation
To assess the performances of the CNV score and set an optimal threshold for prediction, a validation cohort was aggregated. 1020 reliable somatic events were collected from the 31/38 arrays presented here that were hybridized against matching normal DNA samples and presented reliable models. 71 178 polymorphic events were collected from the ESTD212 entry of NCBI dbVar, which consists of 873 high-resolution CytoScan HD arrays performed on healthy volunteers (Uddin et al., 2015) . 8325 segments covered by at least 2 probes from the 105A array design were conserved, enforcing it as the common design for the analysis. All score thresholds were tested to build a Receiver Operating Characteristics (ROC) curve, considering segments with higher scores as polymorphisms (Fig. 3A ). An Area Under the Curve (AUC) of 88.4% was found, suggesting a threshold of 1 as a good trade between sensitivity (82%) and specificity (85%).
A CNV score of 0 was found for 494 somatic segments (48%), suggesting that no DGV supporting variant presented a significant overlap with them (Fig. 3B ). This can be partially explained by the considerably higher size observed in somatic events as compared to polymorphisms (median sizes of 3.1 Mb and 62 kb respectively, P < 1e-16). Similarly, 839 polymorphisms (10%) presented a CNV score of 0, which implies that despite its size, the DGV is not yet able to cover the whole variability of the human genome.
Series processing
Implementation
To prioritize regions of interest in our dataset, the STEPS (Selective Trends Evidenced by Penetrance Surges) detection algorithm was developed. Its purpose is to detect genomic regions consistently altered across samples, as they are more likely to harbor genes whose deregulation is involved in the tumoral process. To detect such regions, altered segments from all samples are first pooled by computing the penetrance for each desired copy number state (amplification, deletion, homozygous deletion. . .), i.e. in each location of the genome the proportion of the sample series that shows the corresponding state.
Breakpoints of copy number alterations are rarely shared across samples, and this is especially visible on high resolution arrays. As a result, the presence of a gene of interest (whose deregulation gives a selective advantage to the tumor) in a given region usually leads to a typical 'stairway' pattern ( Fig. 4A and B) , with the concerned gene on the highest step (the so-called 'Minimal Common Region', or MCR).
The STEPS algorithm locates and prioritizes such patterns by an iterative approach, independently for each desired copy number state (e.g. gains and losses). The chromosome is first sliced into genomic segments of common penetrance for the given copy number state, and local maxima are identified as candidate MCRs. For each MCR, a first score R score is computed iteratively crawling the chromosome from the MCR to the chromosome end, adding every penetrance drop encountered once and subtracting every penetrance rise twice (Algorithm 1). The left score L score is computed similarly from the MCR to the chromosome start, and every pair of left and right scores is combined using Equation 10. The pair yielding the highest mcrScore is then retained for the MCR.
The left and right score combination involves two weights to control the shape of the MCRs. A first weight p advantages boundaries at similar levels of penetrance (Equation 11), while a second weight g advantages boundaries at similar genomic distances from the MCR (Equation 12). Their relative contributions are controlled by exponentiation with user-provided factors (respectively 0.8 and 0.3 as a default). These two weights contribute to penalize unusual MCRs as encountered at the edge of a gained or lost chromosome arm (Fig.  4C) , and to equally prioritize events independently of their context ( Fig. 4B and D) while allowing a few minor events in the computation of the boundaries (Fig. 4A ). As this algorithm emphasizes prioritization, there is no objective threshold for the mcrScore, and regions are intended to be manually reviewed by decreasing score until results are thought too marginal to be further investigated. Statistical significance can still be estimated thanks to permutations of the data if needed, as described in the Supplemental Text.
Application
STEPS results were compared in the same dataset to the last available version of GISTIC (2.0.22), the current reference for the A B analysis of CGH series performed on tumors (Mermel et al., 2011) . Only the 40 963 probes represented in the 3 array designs were retained for each array, as GISTIC requires a common array design. Copy number calling was performed using cghRA and CNVs were filtered using a CNV score threshold of 1, as described above. Four hundred eighty-four MCRs were listed by STEPS in this dataset, with scores ranging from 0.239 to 33.161 (median 1.775, Supplementary Table S2 ). The first 100 STEPS MCRs (scores > 3) and all 47 GISTIC regions (including 18 that were not part of STEPS' top 100) were manually reviewed (Table 1) , using Rgb visualizations, the COSMIC Cancer Gene census (CGC) (Futreal et al., 2004) and available literature on DLBCL.
Fourteen of the 118 curated regions presented patterns suggestive of polymorphism (short segments with identical boundaries, mixing high-level copy number gains and losses), representing 8% of STEPS' top 100 and 28% of the 47 GISTIC regions. While up to 13% false-negatives can be expected according to the CNV score validation presented above, most of these potential polymorphisms were also found in the 38 CGH arrays hybridized against matching normal DNA. The somatic origin of some of these alterations is thus confirmed, but the co-occurrence of high level copy gains and losses still casts doubt on their biological pertinence. Nevertheless 4 of these CNV-like regions harbor genes from the CGC, including TERT, RECQL4, HIST1H4I and CBFA2T3.
Fifty-three of the 118 considered regions were bona fide MCRs, consisting of the superposition of large and distinct segments of a predominant copy number state. Such events with highest STEPS scores and most significant GISTIC q values were copy gains of REL in 2p16 (33.161 and 9.9e-18 respectively) and copy losses of CDKN2A in 9p21 (28.968 and 6.3e-14), two of the most representative events of GCB and ABC DLBCL respectively (Lenz et al., 2008) . 14 other regions were found significant by both STEPS and GISTIC (q < 25%), consisting mainly of known loci such as 1p36 (TNFRSF14), 1p13 (CD58), 6q23 (TNFAIP3) and 19p13 (CD70) (Lenz et al., 2008; Monti et al., 2012; Scandurra et al., 2010) . 38 regions were highlighted by STEPS and were ignored or deemed non-significant by GISTIC, including copy gains of MIR17HG in 13q31 (Lenz et al., 2008) and copy losses of RHOA in 3p21 (O'Hayre et al., 2016) , LPP and MIR28 in 3q27 (Jais et al., 2008; Schneider et al., 2014) , MAPK10 and PTPN13 in 4q21-22 (Ying et al., 2006) , DUSP6 in 12q21 (Zhai et al., 2014) and RCOR1 in 14q32 (Chan et al., 2015) .
Forty-seven of the 118 candidate MCRs were considered 'minor', as they rely on a single segment or a small overlap between two large segments. This implies a larger degree of uncertainty in the presence of driver genes and their positions, as the presence or absence of only one of these segments would have dramatically modified the MCR position. GISTIC was specifically designed to ignore such low-confidence events, and only 5 of them presented a GISTIC q value below the default threshold (q < 25%). Four of these 5 events consisted of a single multi-copy gain, which may constitute higher evidence of pressure selection that STEPS does not presently account for. STEPS scores were significantly lower in these regions (P ¼ 0.008), but no specific filtering was applied as a significant part of these events seem relevant: copy gains involving NFKBIZ in 3q12-13 (Nogai et al., 2013) , RBM14 in 11q13 (Sui et al., 2007) , SIK2 in 11q22-23 (Nagel et al., 2010) and CD36 in Table S2 . Bold values are considered as significant (score > 3 for STEPS, q < 0.25 for GISTIC). (Danilova et al., 2013) , copy losses of SOCS1 in 16p13 (Mottok et al., 2009) and BAZ1A in 14q13 (S anchez-Molina et al., 2011) .
Three of the 118 MCRs corresponding to chromosome ends were missed by STEPS, including a single significant region according to GISTIC (loss of 18q-ter). This can be explained by the penalties applied to asymmetric patterns, which are extreme in such terminal (p-ter or q-ter) loci. Finally a single region was highlighted in 18q21-22 by GISTIC due to clustered break points, putting the focus on BCL2, which is known in DLBCL for frequent translocations (Willis and Dyer, 2000) .
Aside from these classes, seven regions were also considered as 'secondary' MCRs, i.e. regions for which a subset of involved segments may have undergone the selection pressure of a distinct and close region of interest holding another MCR of higher importance. While STEPS offers an argument to filter such MCR nests which was not used in this analysis, GISTIC ignored all of them. None of these regions harbored known genes of interest, so focusing on the highest score inside a MCR nest seems to be a safe choice. Seemingly 8 regions were classified as 'ties', i.e. they showed similar importance to distinct close MCRs.
Discussion
In this study we have proposed an integrated and interfaced workflow for CGH array analysis, and introduced three new algorithms that proved to be more accurate or at least equivalent to current reference software.
The cghRA model for copy calling showed a comparable accuracy and a slightly better sensitivity than GLAD (Hupé et al., 2004) , and generally outperformed CGHcall. The absence of a priori on the copy number states makes cghRA a simple yet flexible model, with only two main parameters ('width' and 'center') that can be tuned manually via an interactive interface. Despite this flexibility, cghRA was unable to automatically model 13 of the 107 arrays (12%), which can appear as a weakness. While six of them could be rescued manually via the interface, the seven remaining samples (6.5%) showed a single noteworthy distribution peak. A first hypothesis for this pattern is that tumor cell contents were very low ('width' tends toward 0), and the expected peaks fused into a single wide peak due to the technical noise. A second hypothesis is that these tumors contained negligible amounts of copy gains and losses, a case in which only a single peak at 2n is expected. A log-ratio based copy number state would be very unreliable in the first case, which justifies this exclusion. However the second hypothesis suggests that it will also exclude tumors with few anomalies, and thus slightly over-estimate the penetrance of gains and losses in a sample series. While GLAD and CGHcall have chosen to systematically report these samples as normal, cghRA default behavior is thus to exclude them. This can however be easily changed, by manually setting its 'width' parameter to the value observed in similar tumors.
The cghRA model was developed to benefit from the specificities of lymphomas, i.e. very few clones with moderate amounts of alterations. Other tumor types can however display more complex subclone architectures, that could represent a challenge for the copy calling models discussed here (cghRA, CGHcall and GLAD), as illustrated in the Supplemental Text. Alternative models can easily be implemented in the cghRA framework to handle such cases, and the traditional threshold-based approach is still proposed natively by cghRA.
The cnvScore algorithm, dedicated to the filtering of polymorphisms, performed well with an AUC of 88.4% in an independent dataset. Polymorphism filtering based on the DGV has often been criticized (Bastida-Lertxundi et al., 2014; Duclos et al., 2011) , but the strict validation scheme applied here proved that the cnvScore yields satisfactory results. Indeed it was able to identify 82% of the 8325 polymorphisms extracted from a series of high resolution arrays not included in the DGV. Manual examination of the false negatives suggested that they were mainly due to the absence of similar regions in the DGV rather than a weakness in the overlap assessment, highlighting the holes that remain in our current knowledge of the human genome variability. At the opposite, 85% of the 1020 segments whose somatic origin was assessed by hybridization against matching normal DNA were correctly assigned by cnvScore. The remaining false-positives could be explained by the known occurrence of somatic events at polymorphic sites, as has been previously demonstrated in hematologic neoplasms (Starczynowski et al., 2011) . Somatic events occurring in such unstable sites are very similar to known polymorphisms, and are thus classified as polymorphisms by the cnvScore. We considered that the biological relevance of copy gains or losses in regions naturally varying between individuals is dubious, and that discarding them from recurrence analyses should have a minimal impact.
The STEPS algorithm for MCR prioritization agreed with GISTIC on most representative events in DLBCL (CDKN2A, REL, TNFRSF14, TNFAIP3 . . .), offering a more portable implementation and a wider sensitivity range. While GISTIC emphasizes statistically sound events, we have demonstrated that several events of known pertinence (MIR17HG, RHOA, MAPK10/PTPN13, RCOR1 . . .) could have been highlighted too, at the cost of more potential false positives and negatives. STEPS allows more flexibility in the sensitivity/specificity trade-off (controlled by the threshold to apply to its score), as even with relaxed parameters GISTIC failed to report these events. This gain of sensitivity is of particular interest in discovery series of modest size like the one presented here, in which statistical significance is achieved only for a few events. The benefits of GISTIC would appear in larger series, in which it would have the ability to extend the minimal common region, which could have been over-narrowed by an artifactual segment. The missing of B2M in 15q15 copy losses, of CD70 in 19p13 or TP53 in 17p13 illustrates this phenomenon, but it should be noted that GISTIC missed them as well in its 'peak' coordinates (confidence level of 0.75), while the 'extended peak' coordinates covered dozens to hundreds of genes. Unlike GISTIC, STEPS was also unable to score regions of interest located near telomeres, for which the expected 'stairway' pattern cannot be observed. A single subtelomeric region was deemed significantly lost by GISTIC (18q23) and thus missed by STEPS, but its biological significance remains to be determined.
Several of the algorithms we developed for CGH arrays are still relevant in most copy-number analyses, whatever the technique used. The usefulness of the density-based copy calling model was indeed illustrated in the context of whole-exome sequencing, in which it allowed a precise estimation of the tumor cell content in conjunction with the variant allele frequency (Mareschal et al., 2016) . However as SNP arrays and NGS offer additional data on heterozygosity, more robust models are still available in these particular fields (Popova et al., 2009; Van Loo et al., 2010) . As these alternative methods usually rely on the same concept of punctual ratios between tumor and reference samples, the cnvScore is likely to survive the progressive retirement of CGH arrays. Finally, the STEPS algorithm offers means to compare altered regions across the genome, whatever the technique used to define them, and provides an appealing alternative to the widely adopted GISTIC.
To conclude, the cghRA suite we introduce here integrates all the required software to perform CGH array data analysis in a series of tumors in a single graphical interface. The quality of the results produced by cghRA were shown to be at least equivalent to current references in the field, and the cnvScore we propose successfully fulfills a need that was not yet addressed in such analyses.
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